Trends in treatment for synchronous colorectal liver metastases: Differences in outcome before and after 2000

Journal of Surgical Oncology

Volumn 102, Issue 5, 2010, Pages 413-418

  Van Der Pool, Anne E M ^a   Lalmahomed, Zarina S ^a   De Wilt, Johannes H W ^a   Eggermont, Alexander M M ^a   Ijzermans, Jan N M ^a   Verhoef, Cornelis ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Colorectal liver metastases; Hepatic resection; Recent trends; Synchronous

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; COLORECTAL CANCER; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LIVER METASTASIS; LIVER RESECTION; MALE; PRIORITY JOURNAL; SURVIVAL RATE; SURVIVAL TIME; SYNCHRONOUS COLORECTAL LIVER METASTASIS; TREND STUDY; COLORECTAL NEOPLASMS; FOLLOW UP; LIVER NEOPLASMS; MIDDLE AGED; PATHOLOGY; SECONDARY; TREATMENT OUTCOME; TUMOR RECURRENCE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; TREATMENT OUTCOME;

EID: 77957331008     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21618     Document Type: Article

References (32)

1. Boyle P, Ferlay J: Cancer incidence and mortality in Europe, 2004. Ann Oncol 2005;16:481-488.
2. American Cancer Society. Cancer Facts and Figures. Available: http://www.cancer.org/docroot. 2002.
3. Adam R, Vinet E: Regional treatment of metastasis: Surgery of colorectal liver metastases. Ann Oncol 2004;15:iv 103-106.
4. Fong Y, Fortner J, Sun RL, et al.: Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 consecutive cases. Ann Surg 1999;230:309-318, discussion 318-321.
5. Sugawara Y, Yamamoto J, Yamasaki S, et al.: Estimating the prognosis of hepatic resection in patients with metastatic liver tumors from colorectal cancer with special concern for the timing of hepatectomy. Surgery 2001;129:408-413. (Pubitemid 32289889)
6. Tsai MS, Su YH, Ho MC, et al.: Clinicopathological features and prognosis in resectable synchronous and metachronous colorectal liver metastasis. Ann Surg Oncol 2007;14:786-794.
7. Adam R, Delvart V, Pascal G, et al.: Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: A model to predict long-term survival. Ann Surg 2004;240:644-657, discussion 657-648.
8. Adam R, Wicherts DA, de Haas RJ, et al.: Patients with initially unresectable colorectal liver metastases: Is there a possibility of cure? J Clin Oncol 2009;27:1829-1835.
9. Abdalla EK, Vauthey JN, Ellis LM, et al.: Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 2004;239:818-825, discussion 825-817.
10. Choti MA, Sitzmann JV, Tiburi MF, et al.: Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 2002;235:759-766.
11. Gruenberger B, Tamandl D, Schueller J, et al.: Bevacizumab, capecitabine, and oxaliplatin as neoadjuvant therapy for patients with potentially curable metastatic colorectal cancer. J Clin Oncol 2008;26:1830-1835.
12. Couinaud C: Liver anatomy: Portal (and suprahepatic) or biliary segmentation. Dig Surg 1999;16:459-467.
13. Mentha G, Majno PE, Andres A, et al.: Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary. Br J Surg 2006;93:872-878. (Pubitemid 44035261)
14. Verhoef C, van der Pool AE, Nuyttens JJ, et al.: The "liver-first approach" for patients with locally advanced rectal cancer and synchronous liver metastases. Dis Colon Rectum 2009;52:23-30.
15. Reddy SK, Pawlik TM, Zorzi D, et al.: Simultaneous resections of colorectal cancer and synchronous liver metastases: A multi-institutional analysis. Ann Surg Oncol 2007;14:3481-3491. (Pubitemid 350160107)
16. Tanaka K, Shimada H, Matsuo K, et al.: Outcome after simultaneous colorectal and hepatic resection for colorectal cancer with synchronous metastases. Surgery 2004;136:650-659. (Pubitemid 39186580)
17. Benoist S, Pautrat K, Mitry E, et al.: Treatment strategy for patients with colorectal cancer and synchronous irresectable liver metastases. Br J Surg 2005;92:1155-1160. (Pubitemid 41284882)
18. Allen PJ, Kemeny N, Jarnagin W, et al.: Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases. J Gastrointest Surg 2003;7:109-115, discussion 116-107.
19. van der Pool AE, Lalmahomed ZS, de Wilt JH, et al.: Local treatment for recurrent colorectal hepatic metastases after partial hepatectomy. J Gastrointest Surg 2009;13:890-895.
20. Petrowsky H, Gonen M, JarnaginW, et al.: Second liver resections are safe and effective treatment for recurrent hepatic metastases from colorectal cancer: A bi-institutional analysis. Ann Surg 2002;235:863-871. (Pubitemid 34547306)
21. Shaw IM, Rees M, Welsh FK, et al.: Repeat hepatic resection for recurrent colorectal liver metastases is associated with favourable long-term survival. Br J Surg 2006;93:457-464.
22. Jarnagin WR, Gonen M, Fong Y, et al.: Improvement in perioperative outcome after hepatic resection: Analysis of 1,803 consecutive cases over the past decade. Ann Surg 2002;236:397-406, discussion 406-397.
23. McColl RJ, You X, Ghali WA, et al.: Recent trends of hepatic resection in Canada: 1995-2004. J Gastrointest Surg 2008;12:1839-1846, discussion 1846.
24. Dimick JB, Cowan JA, Jr., Knol JA, et al.: Hepatic resection in the United States: Indications, outcomes, and hospital procedural volumes from a nationally representative database. Arch Surg 2003;138:185-191.
25. Nojiri K, Nagano Y, Tanaka K, et al.: Validity of hepatic resection of colorectal liver metastases in the elderly (75 years and older). Anticancer Res 2009;29:583-588.
26. Bolton JS, Fuhrman GM: Survival after resection of multiple bilobar hepatic metastases from colorectal carcinoma. Ann Surg 2000;231:743-751. (Pubitemid 30249836)
27. Kornprat P, Jarnagin WR, Gonen M, et al.: Outcome after hepatectomy for multiple (four or more) colorectal metastases in the era of effective chemotherapy. Ann Surg Oncol 2007;14:1151-1160.
28. Adam R, de Haas RJ, Wicherts DA, et al.: Is hepatic resection justified after chemotherapy in patients with colorectal liver metastases and lymph node involvement? J Clin Oncol 2008;26:3672-3680.
29. de Haas RJ, Wicherts DA, Flores E, et al.: R1 resection by necessity for colorectal liver metastases: Is it still a contraindication to surgery? Ann Surg 2008;248:626-637.
30. Adam R, Miller R, Pitombo M, et al.: Two-stage hepatectomy approach for initially unresectable colorectal hepatic metastases. Surg Oncol Clin N Am 2007;16:525-536 viii. (Pubitemid 46990942)
31. Pawlik TM, Vauthey JN: Surgical margins during hepatic surgery for colorectal liver metastases: Complete resection not millimeters defines outcome. Ann Surg Oncol 2008;15:677-679.
32. Hurwitz H, Fehrenbacher L, Novotny W, et al.: Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004;350:2335-2342. (Pubitemid 38702844)